Comparative efficacy of 5 sodium-glucose cotransporter protein-2 (SGLT-2) inhibitor and 4 glucagon-like peptide-1 (GLP-1) receptor agonist drugs in non-alcoholic fatty liver disease: A GRADE-assessed systematic review and network meta-analysis of randomized controlled trials

Background: The relative efficacy of 5 sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and 4 glucagon-like peptide-1 (GLP-1) receptor agonists for non-alcoholic fatty liver disease (NAFLD) therapy has not been sufficiently investigated. Methods: Randomized controlled trials (RCTs) in whic...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Yunpeng, Sun, Lei, Zhang, Wei, Kong, Tingting, Zhou, Run, He, Yining, Deng, Chaohua, Yang, Luping, Kong, Jianing, Chen, Yutong, Shi, Junping, Hu, Yanli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040540/
https://www.ncbi.nlm.nih.gov/pubmed/36992825
http://dx.doi.org/10.3389/fphar.2023.1102792

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040540/
https://www.ncbi.nlm.nih.gov/pubmed/36992825
http://dx.doi.org/10.3389/fphar.2023.1102792

Ejemplares similares